» Articles » PMID: 22193044

Entrainment of Breast (cancer) Epithelial Cells Detects Distinct Circadian Oscillation Patterns for Clock and Hormone Receptor Genes

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2011 Dec 24
PMID 22193044
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Most physiological and biological processes are regulated by endogenous circadian rhythms under the control of both a master clock, which acts systemically and individual cellular clocks, which act at the single cell level. The cellular clock is based on a network of core clock genes, which drive the circadian expression of non-clock genes involved in many cellular processes. Circadian deregulation of gene expression has emerged to be as important as deregulation of estrogen signaling in breast tumorigenesis. Whether there is a mutual deregulation of circadian and hormone signaling is the question that we address in this study. Here we show that, upon entrainment by serum shock, cultured human mammary epithelial cells maintain an inner circadian oscillator, with key clock genes oscillating in a circadian fashion. In the same cells, the expression of the estrogen receptor α (ER A) gene also oscillates in a circadian fashion. In contrast, ER A-positive and -negative breast cancer epithelial cells show disruption of the inner clock. Further, ER A-positive breast cancer cells do not display circadian oscillation of ER A expression. Our findings suggest that estrogen signaling could be affected not only in ER A-negative breast cancer, but also in ER A-positive breast cancer due to lack of circadian availability of ER A. Entrainment of the inner clock of breast epithelial cells, by taking into consideration the biological time component, provides a novel tool to test mechanistically whether defective circadian mechanisms can affect hormone signaling relevant to breast cancer.

Citing Articles

Circadian rhythms and breast cancer: from molecular level to therapeutic advancements.

Li D, Zhou T, Gao J, Wu G, Yang G J Cancer Res Clin Oncol. 2024; 150(9):419.

PMID: 39266868 PMC: 11393214. DOI: 10.1007/s00432-024-05917-w.


Krüppel-like factor 9 (KLF9) links hormone dysregulation and circadian disruption to breast cancer pathogenesis.

Ybanez W, Bagamasbad P Cancer Cell Int. 2023; 23(1):33.

PMID: 36823570 PMC: 9948451. DOI: 10.1186/s12935-023-02874-1.


Major roles of the circadian clock in cancer.

Huang C, Zhang C, Cao Y, Li J, Bi F Cancer Biol Med. 2023; 20(1).

PMID: 36647780 PMC: 9843445. DOI: 10.20892/j.issn.2095-3941.2022.0474.


Melatonin Regulates the Daily Levels of Plasma Amino Acids, Acylcarnitines, Biogenic Amines, Sphingomyelins, and Hexoses in a Xenograft Model of Triple Negative Breast Cancer.

Junior R, de Almeida Chuffa L, Simao V, Sonehara N, Chammas R, Reiter R Int J Mol Sci. 2022; 23(16).

PMID: 36012374 PMC: 9408859. DOI: 10.3390/ijms23169105.


Circadian Alterations Increase with Progression in a Patient-Derived Cell Culture Model of Breast Cancer.

Lin H, Taylor S, Farkas M Clocks Sleep. 2021; 3(4):598-608.

PMID: 34842634 PMC: 8628750. DOI: 10.3390/clockssleep3040042.


References
1.
Lee C . Tumor suppression by the mammalian Period genes. Cancer Causes Control. 2006; 17(4):525-30. DOI: 10.1007/s10552-005-9003-8. View

2.
Moser M, Schaumberger K, Schernhammer E, Stevens R . Cancer and rhythm. Cancer Causes Control. 2006; 17(4):483-7. DOI: 10.1007/s10552-006-0012-z. View

3.
Chen S, Choo K, Hou M, Yeh K, Kuo S, Chang J . Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis. 2005; 26(7):1241-6. DOI: 10.1093/carcin/bgi075. View

4.
Canaple L, Kakizawa T, Laudet V . The days and nights of cancer cells. Cancer Res. 2003; 63(22):7545-52. View

5.
Haus E, Smolensky M . Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control. 2006; 17(4):489-500. DOI: 10.1007/s10552-005-9015-4. View